PUBLISHER: The Business Research Company | PRODUCT CODE: 1710338
PUBLISHER: The Business Research Company | PRODUCT CODE: 1710338
Genomic Biomarkers Global Market Report 2025
Genomic biomarkers are specific sequences or variations in DNA or RNA that provide insights into biological processes, conditions, or responses to treatments. In precision medicine, these biomarkers help predict disease risk, diagnose conditions, monitor disease progression, or guide treatment decisions. They are essential for personalized medicine, enabling healthcare providers to tailor treatments based on an individual's genetic makeup, thereby enhancing therapy effectiveness and minimizing adverse effects.
The main types of genomic biomarkers are predictive biomarkers and prognostic biomarkers. Predictive biomarkers are biological molecules found in blood, other body fluids, or tissues that indicate whether a patient is likely to benefit from a specific medical treatment or intervention. They are relevant for various disease indications, including oncology, cardiovascular diseases, neurological diseases, renal disorders, and others, and are validated through analytical, clinical, and clinical utility validations. These biomarkers are utilized by end-users such as hospitals, diagnostic centers, and other healthcare providers.
The genomic biomarkers market research report is one of a series of new reports from The Business Research Company that provides genomic biomarkers market statistics, including genomic biomarkers industry global market size, regional shares, competitors with a genomic biomarkers market share, detailed genomic biomarkers market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic biomarkers industry. This genomic biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genomic biomarkers market size has grown rapidly in recent years. It will grow from $7.42 $ billion in 2024 to $8.72 $ billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to the rising emphasis on various genetic testing activities, growing cases of chronic diseases, growing emphasis on precision medicine initiatives, growing adoption of companion diagnostics, and rising number of patients with neurological diseases.
The genomic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $16.51 $ billion in 2029 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to the increasing number of ovarian and gastric cancer cases, growing acceptance and awareness of genetic testing, increasing use of genomic biomarkers in cancer diagnosis and treatment, increasing number of cancer patients, and growing adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), integration with other omics, genomic technological advancements, product innovations, and advanced healthcare services.
The growing demand for personalized medicine is projected to drive the expansion of the genomic biomarkers market. Personalized medicine, or precision medicine, tailors healthcare decisions and treatments to the unique characteristics of each patient, primarily based on their genetic and genomic information. This demand is fueled by factors such as increased focus on patient-centered care, advancements in genetic sequencing and analysis, the shift towards a patient-centric approach, and the utilization of electronic health records (EHRs) for managing patient data. Genomic biomarkers are essential in personalized medicine as they enable healthcare providers to customize medical treatments according to an individual's specific genetic profile, thereby optimizing treatment effectiveness and reducing side effects. For instance, the Personalized Medicine Coalition reported in 2022 that 12 new personalized medications were approved, representing approximately 34% of all newly approved treatments and a 34% increase over previous years. As such, the rising demand for personalized medicine is expected to accelerate growth in the genomic biomarkers market.
Key players in the genomic biomarkers market are concentrating on developing advanced products, such as lung reagents, to enhance the detection of specific genetic mutations in lung cancer, improve diagnostic accuracy, and support personalized treatment strategies through advanced genomic technologies. Lung reagents are specialized substances used in diagnostic tests and research related to lung conditions, facilitating precision medicine by guiding treatment based on the genetic profile of the cancer. For example, in December 2023, Biofidelity, a UK-based company specializing in advanced genomic assays and precision diagnostics, introduced ASPYRE-Lung reagents. These reagents are designed to detect significant genetic mutations and alterations in lung cancer, crucial for directing targeted therapies and personalized treatment plans.
In November 2022, Biocare Medical, a US-based manufacturer of immunohistochemistry (IHC) and molecular pathology products for cancer and infectious disease diagnostics, acquired Empire Genomics LLC for an undisclosed amount. This acquisition is intended to enhance Biocare Medical's capabilities in precision diagnostics and molecular pathology. Empire Genomics LLC, also based in the US, produces genomic biomarkers used in cancer diagnosis and personalized medicine.
Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4
North America was the largest region in the genomic biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genomic biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genomic biomarkers market consists of sales of genomic biomarker panels, real-time PCR detection systems, and droplet digital PCR (ddPCR) systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genomic Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genomic biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genomic biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Predictive Biomarkers; Prognostic Biomarkers
- 2) By Disease Indication: Oncology; Cardiovascular Diseases; Neurological Diseases; Renal Disorders; Other Disease Indications
- 3) By Validation: Analytical Validation; Clinical Validation; Clinical Utility
- 4) By End-User: Hospitals; Diagnostic Centers; Other End User
- Subsegments:
- 1) By Predictive Biomarkers: Drug Response Biomarkers; Companion Diagnostics Biomarkers; Pharmacodynamic Biomarkers; Predictive Genetic Markers for Disease Susceptibility
- 2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers; Cardiovascular Disease Prognostic Biomarkers; Neurodegenerative Disease Prognostic Biomarkers; Infectious Disease Prognostic Biomarkers
- Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd.; Illumina Inc.; PerkinElmer Inc.; Almac Group
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Genomic Biomarkers Market Characteristics
3. Genomic Biomarkers Market Trends And Strategies
4. Genomic Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Genomic Biomarkers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Genomic Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Genomic Biomarkers Market Growth Rate Analysis
- 5.4. Global Genomic Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Genomic Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Genomic Biomarkers Total Addressable Market (TAM)
6. Genomic Biomarkers Market Segmentation
- 6.1. Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Predictive Biomarkers
- Prognostic Biomarkers
- 6.2. Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- 6.3. Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Analytical Validation
- Clinical Validation
- Clinical Utility
- 6.4. Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Other End User
- 6.5. Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Response Biomarkers
- Companion Diagnostics Biomarkers
- Pharmacodynamic Biomarkers
- Predictive Genetic Markers for Disease Susceptibility
- 6.6. Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer Prognostic Biomarkers
- Cardiovascular Disease Prognostic Biomarkers
- Neurodegenerative Disease Prognostic Biomarkers
- Infectious Disease Prognostic Biomarkers
7. Genomic Biomarkers Market Regional And Country Analysis
- 7.1. Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genomic Biomarkers Market
- 8.1. Asia-Pacific Genomic Biomarkers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genomic Biomarkers Market
- 9.1. China Genomic Biomarkers Market Overview
- 9.2. China Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genomic Biomarkers Market
- 10.1. India Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genomic Biomarkers Market
- 11.1. Japan Genomic Biomarkers Market Overview
- 11.2. Japan Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genomic Biomarkers Market
- 12.1. Australia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genomic Biomarkers Market
- 13.1. Indonesia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genomic Biomarkers Market
- 14.1. South Korea Genomic Biomarkers Market Overview
- 14.2. South Korea Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genomic Biomarkers Market
- 15.1. Western Europe Genomic Biomarkers Market Overview
- 15.2. Western Europe Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genomic Biomarkers Market
- 16.1. UK Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genomic Biomarkers Market
- 17.1. Germany Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genomic Biomarkers Market
- 18.1. France Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genomic Biomarkers Market
- 19.1. Italy Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genomic Biomarkers Market
- 20.1. Spain Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genomic Biomarkers Market
- 21.1. Eastern Europe Genomic Biomarkers Market Overview
- 21.2. Eastern Europe Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genomic Biomarkers Market
- 22.1. Russia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genomic Biomarkers Market
- 23.1. North America Genomic Biomarkers Market Overview
- 23.2. North America Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genomic Biomarkers Market
- 24.1. USA Genomic Biomarkers Market Overview
- 24.2. USA Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genomic Biomarkers Market
- 25.1. Canada Genomic Biomarkers Market Overview
- 25.2. Canada Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genomic Biomarkers Market
- 26.1. South America Genomic Biomarkers Market Overview
- 26.2. South America Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genomic Biomarkers Market
- 27.1. Brazil Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genomic Biomarkers Market
- 28.1. Middle East Genomic Biomarkers Market Overview
- 28.2. Middle East Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genomic Biomarkers Market
- 29.1. Africa Genomic Biomarkers Market Overview
- 29.2. Africa Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genomic Biomarkers Market Competitive Landscape And Company Profiles
- 30.1. Genomic Biomarkers Market Competitive Landscape
- 30.2. Genomic Biomarkers Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Almac Group Overview, Products and Services, Strategy and Financial Analysis
31. Genomic Biomarkers Market Other Major And Innovative Companies
- 31.1. Azenta Inc.
- 31.2. Novogene Corporation
- 31.3. Oxford Nanopore Technologies Ltd.
- 31.4. Celerion
- 31.5. Quanterix Corporation
- 31.6. Bio-Rad Laboratories Inc.
- 31.7. NantHealth Inc.
- 31.8. Centogene N.V.
- 31.9. Sophia Genetics SA
- 31.10. Envisagenics
- 31.11. Deep Genomics
- 31.12. Creative Diagnostics
- 31.13. Macrogen Inc.
- 31.14. Guardant Health Inc.
- 31.15. Sema4
32. Global Genomic Biomarkers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genomic Biomarkers Market
34. Recent Developments In The Genomic Biomarkers Market
35. Genomic Biomarkers Market High Potential Countries, Segments and Strategies
- 35.1 Genomic Biomarkers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Genomic Biomarkers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Genomic Biomarkers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
